General Archive
-
Ventures funding, News releases
LifeArc Ventures invests in Surgery Hero, world’s first digital coaching clinic for patients
Seed funding will be used to scale the solution through the application of machine learning
-
News releases
Call for Government to place medical research at the heart of economic plans
Ahead of the Autumn Statement, LifeArc and other leading life science organisations have written to the Chancellor calling for the…
-
News releases
LifeArc joins forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to strengthen antimicrobial discovery efforts
Pivotal partnership seeks to transform Cystic Fibrosis research
-
News releases, Articles & blogs
Separate science from politics: save the UK’s science sector
LifeArc’s Chief Scientific Officer calls for UK science to continue to be a contributor to the Horizon Europe programme.
-
News releases
Promising new antibody treatment for osteoporosis and multiple sclerosis
The new antibody offers hope of an effective new treatment option for millions of people.
-
News releases
Her Majesty Queen Elizabeth II
We at LifeArc are deeply saddened by the passing of Her Majesty Queen Elizabeth II.
-
Ventures funding, News releases
LifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million
First exit for LifeArc Ventures, the largest investor in Ducentis, recognising the transformational potential of its science
-
News releases
LifeArc helps create new MRC spin-out company
The new company aims to re-programme microbes to enable new materials to be produced – such as drugs and biodegradable…
-
News releases
Driving translational research into childhood rare diseases
Four grants awarded to projects that aim to translate research discoveries into benefits for children affected by rare diseases
-
News releases
New £4.25 million grant kick starts UK-wide collaborative research effort to end motor neuron disease
Collaboration will work together to find solutions to MND within years, not decades
-
News releases
New £30 million translational partnership will accelerate development of new treatments for people with dementia
Funding will accelerate development of new diagnostic tests, treatments, and devices for people with dementia.
-
News releases
Promising new asthma medicine ready to enter early clinical trials
LifeArc scientists instrumental to the development of the world’s first anti-IL17BR antibody, now being trialled as a treatment for severe…